glp-1 prescriptions growth slowing 2024 Quadruple Since 2021 Alongside Decline In Obesity Pharma Giants Bet on Next-Generation

Texans may recognize the following brand names of GLP-1 weight loss drugs: Ozempic (semaglutide from Novo Nordisk) Rybelsus (semaglutide from Novo Nordisk) Wegovy (semaglutide from Novo Nordisk) Mounjaro (tirzepatide from Eli Lilly and Company) Zepbound (tirzepatide from Eli Lilly and Company) Saxenda (liraglutide from Novo Nordisk) Victoza (liraglutide from Novo Nordisk) Trulicity (dulaglutide from Eli Lilly and Company) Bursor & Fisher, P.A

Humanized receptor mouse models express the human targets of these drug candidates, enabling in vivo efficacy and safety evaluation and helping researchers better predict the clinical performance of new obesity and diabetes therapies

Ozempic is a diabetes medication that may also lead to weight loss

No serious adverse reactions were reported

But some people find it harder than others to stop snacking